98 related articles for article (PubMed ID: 7408664)
1. [Effectiveness of proxyphylline in chronic obstructive pulmonary disease (author's transl)].
Geisler LS; Thiel H; Förster OB; Rohner HG
Dtsch Med Wochenschr; 1980 Jun; 105(25):894-7. PubMed ID: 7408664
[TBL] [Abstract][Full Text] [Related]
2. [(Whole body plethysmographic studies on the bronchospasmolytic effect of injectabls drugs. Comparison of aminophylline, diprophylline and hexoprenaline)].
Kaik G
Int J Clin Pharmacol Biopharm; 1976 Oct; 14(3):177-85. PubMed ID: 137218
[TBL] [Abstract][Full Text] [Related]
3. [Theophylline blood levels after administration of Euphyllin retard (author's transl)].
Ahrens J
Dtsch Med Wochenschr; 1977 Apr; 102(13):482-6. PubMed ID: 844428
[TBL] [Abstract][Full Text] [Related]
4. [Effect of slow-release aminophylline on pulmonary function in obstructive respiratory disease(author's transl)].
Wiessmann KJ
Dtsch Med Wochenschr; 1975 Sep; 100(36):1781-90. PubMed ID: 1098887
[TBL] [Abstract][Full Text] [Related]
5. [Comparative examination of theophylline-serum-concentrations and bronchospasmolytic effect of cholintheophyllinate (euspirax) and theophyllin-aethylendiamine (euphyllin retard) in patients with obstructive airway diseases (author's transl)].
Wettengel R; Oellerich M; Schnitker J
Prax Klin Pneumol; 1979 Nov; 33(11):1125-31. PubMed ID: 523424
[TBL] [Abstract][Full Text] [Related]
6. [Lung functions and blood levels after parenteral administration of theophylline-ethylenediamine (author's transl)].
Wiessmann KJ; Schulz HU
Dtsch Med Wochenschr; 1977 Dec; 102(52):1916-20. PubMed ID: 598301
[TBL] [Abstract][Full Text] [Related]
7. [Bronchospasmolytic effectiveness of controlled drug combinations].
Forche G; Zenker G; Harnoncourt K
Wien Med Wochenschr; 1986 May; 136(9):213-8. PubMed ID: 3739357
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetics and pharmacodynamics of proxyphylline in asthmatic children].
Kalla M; Richter O; Reinhardt D
Monatsschr Kinderheilkd; 1985 Aug; 133(8):520-6. PubMed ID: 4047067
[TBL] [Abstract][Full Text] [Related]
9. [Effect and side effects of a depot theophylline preparation within the scope of a clinical trial].
Wilke A; Weinecke A; Weide W; Schäfer K; Iwainsky H
Z Erkr Atmungsorgane; 1986; 167(3):245-53. PubMed ID: 3551350
[TBL] [Abstract][Full Text] [Related]
10. [Heart rhythm changes in patients with chronic obstructive bronchopneumopathies: effects of different methylxanthine drugs].
Cipri A; Pozzar F; Dini FL
Minerva Cardioangiol; 1992; 40(1-2):31-9. PubMed ID: 1630668
[TBL] [Abstract][Full Text] [Related]
11. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease.
Fontana G; Cresci F; Lo Sapio P; Panuccio P
Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and bronchodilatory effect of proxyphylline and theophylline.
Rasmussen FV; Waldorff S; Madsen L
Eur J Respir Dis; 1984 Jan; 65(1):20-7. PubMed ID: 6705854
[TBL] [Abstract][Full Text] [Related]
13. [The effect of long-term oral administration of a bronchodilator, a sustained-release aminophylline preparation, on pulmonary function (author's transl)].
Wiessmann KJ
Dtsch Med Wochenschr; 1975 Nov; 100(48):2482-6. PubMed ID: 1201724
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of chronic obstructive respiratory disease with a new purified theophylline preparation in delayed-action form].
Kaik G
Wien Med Wochenschr; 1984 Apr; 134(7):163-9. PubMed ID: 6741156
[TBL] [Abstract][Full Text] [Related]
15. [Effect of theophylline-ethylenediamine in obstructive lung disease (author's transl)].
Brossmann D; Ruf G; Wiessmann KJ
Dtsch Med Wochenschr; 1980 Mar; 105(12):410-3. PubMed ID: 7363785
[TBL] [Abstract][Full Text] [Related]
16. [Tolerance and effect of short-term theophylline infusions].
Schmidt M
Pneumologie; 1993 Jan; 47(1):30-5. PubMed ID: 8437976
[TBL] [Abstract][Full Text] [Related]
17. [A single dose of theophylline in the evening in chronic obstructive airway disease. Serum concentration and lung function parameter].
Kaik G
Fortschr Med; 1984 Nov; 102(43):1120-2. PubMed ID: 6510864
[TBL] [Abstract][Full Text] [Related]
18. Comparison of standard- and sustained-release theophylline tablets in patients with chronic obstructive pulmonary disease.
Dasta J; Mirtallo JM; Altman M
Am J Hosp Pharm; 1979 May; 36(5):613-7. PubMed ID: 453214
[No Abstract] [Full Text] [Related]
19. Effect of theophylline in chronic obstructive lung disease.
Umut S; Gemicioğlu B; Yildirim N; Barlas A; Ozüner Z
Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):149-52. PubMed ID: 1592541
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficiency of neobiphyllineR-studies on lung function and serum levels after rectal application of a combination of methyl-xanthines.
Loytved G; Werdermann K; Jorde W; Petro W
Agents Actions Suppl; 1983; 13():131-40. PubMed ID: 6346832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
